Comparative efficacy and safety of three fixed‐ratio combination products in type 2 diabetes: A network meta‐analysis
Abstract Objective To systematically evaluate and compare the efficacy and safety of three fixed‐ratio combination products—insulin degludec/liraglutide (IDegLira), insulin glargine/lixisenatide (iGlarLixi), and insulin degludec/insulin aspart (IDegAsp)—in patients with type 2 diabetes. Methods We s...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wiley
2026-06-01
|
| Sarja: | Journal of Diabetes Investigation |
| Aiheet: | |
| Linkit: | https://doi.org/10.1111/jdi.70293 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|